Colin brings over 25 years of global executive experience, including as director of global corporate finance at Arthur Andersen. Over the past 10 years, Colin has been a market leader in the life sciences space, developing and bringing to market new data capture and advanced statistical analytics solutions for pharma and biotech partners undertaking clinical trials. Immediately prior to joining Anju, Colin served as the CEO of Clintara, which led to the company being acquired by Bracket (a Parthenon Capital Partners company), and subsequently joined the senior executive leadership team at Bracket through Bracket’s acquisition by Genstar Capital. Colin drove exponential growth at both companies prior to their acquisitions, generating substantial shareholder returns for both sets of shareholders. Colin received his BA from McGill University and master’s degree in business administration from The University of Chicago.